Renalytix Ai, Inc.
NPI 1700420361 · Clinical Medical Laboratory · New York, NY
Enrolled with Medicare as Part B Supplier - Independent Clinical Laboratory · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Renalytix Ai, Inc. is a Clinical Medical Laboratory organization in New York, NY (NPI 1700420361).
Provider details
- NPI number
- 1700420361
- Entity type
- Organization
- Primary specialty
- Clinical Medical LaboratoryLaboratories
- Organization subpart
- No
- Authorized official
- James Mccullough, Ceo(888) 203-2725
Specialties & taxonomies
Laboratories
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
6 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
439 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Measurement of Soluble Tumor Necrosis Factor Receptor 1 (stnfr1), Soluble Tumor Necrosis Receptor 2 (stnfr2), and Kidney Injury Molecule 1 (kim-1) to Evaluate Risk of Progressive Decline in Kidney Function in Diabetic Chronic Kidney Disease0407U | 267 | $924 |
| Measurement of Tumor Necrosis Factor Receptor 1a, Receptor Superfamily 2 (tnfr1, Tnfr2), and Kidney Injury Molecule-1 (kim-1) in Plasma to Evaluate Risk of Rapid Kidney Function Decline0105U | 172 | $931 |
Typical Medicare-allowed amounts for these services range $924–$931 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
Practice location
Mailing address
Registry dates
- Enumerated
- 2019-11-06
- Last updated
- 2025-06-18
- Certified
- 2025-06-18
Frequently asked questions
- What is Renalytix Ai, Inc.'s NPI number?
- Renalytix Ai, Inc.'s National Provider Identifier (NPI) is 1700420361, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What type of organization is Renalytix Ai, Inc.?
- Renalytix Ai, Inc. is classified in the NPPES registry as Clinical Medical Laboratory (Laboratories).
- Where is Renalytix Ai, Inc. located?
- Renalytix Ai, Inc.'s practice location on file with NPPES is 101 6th Ave Fl 3, New York, NY 10013-1942.
- What is Renalytix Ai, Inc.'s phone number?
- The practice phone number listed in the NPPES registry for Renalytix Ai, Inc. is (646) 397-3970.
- Does Renalytix Ai, Inc. accept Medicare?
- Renalytix Ai, Inc. is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Who is the authorized official for Renalytix Ai, Inc.?
- The authorized official listed on Renalytix Ai, Inc.'s NPPES record is James Mccullough, Ceo. The authorized official registers and maintains the organization's NPI and is not necessarily its owner.
- Is Renalytix Ai, Inc.'s NPI active?
- Yes — Renalytix Ai, Inc.'s NPI (1700420361) is active in the NPPES registry as of the last update on 2025-06-18.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.